In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin hydrogel

M Konishi, Y Tabata, M Kariya, H Hosseinkhani… - Journal of Controlled …, 2005 - Elsevier
The objective of this paper is to investigate the in vivo anti-tumor effect by dual release of
cisplatin (CDDP) and adriamycin (ADM) from a biodegradable hydrogel. Hydrogels with …

In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin hydrogel.

M Konishi, Y Tabata, M Kariya… - Journal of Controlled …, 2004 - europepmc.org
The objective of this paper is to investigate the in vivo anti-tumor effect by dual release of
cisplatin (CDDP) and adriamycin (ADM) from a biodegradable hydrogel. Hydrogels with …

[引用][C] In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin hydrogel

M KONISHI, Y TABATA, M KARIYA… - Journal of …, 2005 - pascal-francis.inist.fr
In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable
gelatin hydrogel CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

[引用][C] In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin hydrogel

M KONISHI - J Control Release, 2005 - cir.nii.ac.jp
In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin
hydrogel | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …

In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin hydrogel

M Konishi, Y Tabata, M Kariya… - … : official journal of …, 2005 - pubmed.ncbi.nlm.nih.gov
The objective of this paper is to investigate the in vivo anti-tumor effect by dual release of
cisplatin (CDDP) and adriamycin (ADM) from a biodegradable hydrogel. Hydrogels with …

In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin hydrogel

M Konishi, Y Tabata, M Kariya, H Hosseinkhani… - Journal of Controlled …, 2005 - infona.pl
The objective of this paper is to investigate the in vivo anti-tumor effect by dual release of
cisplatin (CDDP) and adriamycin (ADM) from a biodegradable hydrogel. Hydrogels with …

[引用][C] In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin hydrogel

M Konishi, Y Tabata, M Kariya… - JOURNAL OF …, 2005 - repository.kulib.kyoto-u.ac.jp
Kyoto University Research Information Repository: In vivo anti-tumor effect of dual release of
cisplatin and adriamycin from biodegradable gelatin hydrogel Skip navigation ホーム ブラウズ …

[引用][C] In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin hydrogel

M Konishi, Y Tabata, M Kariya… - Journal of Controlled …, 2005 - cir.nii.ac.jp
In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin
hydrogel | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …

[引用][C] In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin hydrogel

M KONISHI, Y TABATA, M KARIYA… - Journal of controlled …, 2005 - Elsevier